We are live on ! Find out more
Man Group

Man Group Portfolio holdings

AUM $55.1B
1-Year Est. Return 24.23%
This Fund
S&P 500
This Quarter Est. Return
+6.87%
1 Year Est. Return
+24.23%
3 Year Est. Return
+82.67%
5 Year Est. Return
+105.49%
10 Year Est. Return
AUM
$27.4B
AUM Growth
+$3.07B
Cap. Flow
+$1.42B
Cap. Flow %
5.18%
Top 10 Hldgs %
10.35%
Holding
2,341
New
253
Increased
935
Reduced
788
Closed
276

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$230M
2
EXC icon
Exelon
EXC
+$186M
3
MSFT icon
Microsoft
MSFT
+$151M
4
MDT icon
Medtronic
MDT
+$136M
5
ALL icon
Allstate
ALL
+$128M

Sector Composition

Rank Sector Weight
1 Financials 15.76%
2 Healthcare 15.63%
3 Technology 15.47%
4 Consumer Discretionary 10.48%
5 Industrials 10.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARII
1876
DELISTED
American Railcar Industries, Inc.
ARII
$304K ﹤0.01%
+6,604
New +$298K
IO
1877
DELISTED
ION Geophysical Corporation
IO
$301K ﹤0.01%
+19,380
New +$378K
LITE icon
1878
Lumentum
LITE
$59.4B
$300K ﹤0.01%
5,000
+4,454
+816% +$266K
MDXG icon
1879
MiMedx Group
MDXG
$626M
$300K ﹤0.01%
48,571
+20,771
+75% +$93.9K
GBT
1880
DELISTED
Global Blood Therapeutics, Inc.
GBT
$300K ﹤0.01%
7,901
-1,027
-12% -$45.5K
UROV
1881
DELISTED
Urovant Sciences Ltd.
UROV
$300K ﹤0.01%
+25,000
New +$296K
GES
1882
DELISTED
Guess Inc
GES
$297K ﹤0.01%
13,155
-74,225
-85% -$1.68M
MGPI icon
1883
MGP Ingredients
MGPI
$378M
$297K ﹤0.01%
+3,759
New +$306K
TYL icon
1884
Tyler Technologies
TYL
$12.2B
$297K ﹤0.01%
1,213
-11,435
-90% -$2.72M
XENT
1885
DELISTED
Intersect ENT, Inc
XENT
$296K ﹤0.01%
10,289
+2,509
+32% +$75.4K
MDP
1886
DELISTED
Meredith Corporation
MDP
$296K ﹤0.01%
+5,804
New +$303K
ASH icon
1887
Ashland
ASH
$3.04B
$294K ﹤0.01%
3,515
-3,943
-53% -$329K
CDXS icon
1888
Codexis
CDXS
$135M
$294K ﹤0.01%
+17,162
New +$277K
ARW icon
1889
Arrow Electronics
ARW
$10.9B
$293K ﹤0.01%
+3,964
New +$304K
GIC icon
1890
Global Industrial
GIC
$1.34B
$293K ﹤0.01%
+8,894
New +$337K
TBPH icon
1891
Theravance Biopharma
TBPH
$874M
$292K ﹤0.01%
+8,942
New +$244K
STR
1892
DELISTED
Sitio Royalties
STR
$288K ﹤0.01%
+6,550
New +$284K
COLL icon
1893
Collegium Pharmaceutical
COLL
$1.14B
$287K ﹤0.01%
+19,445
New +$345K
WVE icon
1894
Wave Life Sciences
WVE
$1.12B
$287K ﹤0.01%
+5,748
New +$259K
OMER icon
1895
Omeros
OMER
$709M
$286K ﹤0.01%
+11,732
New +$262K
LPT
1896
DELISTED
Liberty Property Trust
LPT
$285K ﹤0.01%
6,746
-355
-5% -$15.4K
ATRA icon
1897
Atara Biotherapeutics
ATRA
$71.2M
$277K ﹤0.01%
+268
New +$262K
RCKT icon
1898
Rocket Pharmaceuticals
RCKT
$348M
$277K ﹤0.01%
+11,258
New +$244K
LGTY
1899
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$273K ﹤0.01%
+22,513
New +$340K
FIVN icon
1900
FIVE9
FIVN
$1.77B
$271K ﹤0.01%
6,197
-7,075
-53% -$292K

Similar funds

Man Group's Q3 2018 Portfolio in Review

As of Q3 2018, Man Group held 2,341 positions worth $27.4B, up 13% from $24.3B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Man Group deployed $1.42B of net new capital in Q3 2018, opening 253 new positions and adding to 935 existing holdings. Its largest new stake was Seadrill Limited Common Stock: 5,606,327 shares worth $139M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $296M trimmed.

  • Man Group's largest Q3 2018 buy was Seadrill Limited Common Stock: 5,606,327 shares worth $139M.
  • Man Group added most to Procter & Gamble in Q3 2018, an estimated $230M increase.
  • Man Group's biggest Q3 2018 reduction was Meta Platforms (Facebook), cutting an estimated $296M.
  • Man Group fully exited Fibria Celulose Sa in Q3 2018, selling an estimated $66.4M.
  • Man Group's ten largest holdings make up 10% of its $27.4B portfolio in Q3 2018.
  • Man Group opened 253 new positions and closed 276 in Q3 2018.
  • Man Group's portfolio value rose 13% quarter-over-quarter to $27.4B.

Based on Man Group's 13F filing for Q3 2018, filed 14 Nov 2018.